#None #Waystar #Q2 2026 #Healthcare Payment Software

Waystar's Noteworthy Performance in Q2 2026

Overview

Waystar Holding Corp., listed on Nasdaq under the ticker symbol WAY, has shared its financial outcomes for the second quarter ending June 30, 2026. This quarter marks a solid performance for the company, showcasing notable growth in both revenue and net income. The healthcare payment software provider has benefitted from increased market demand, effective operational execution, and greater provider adoption.

Q2 2026 Key Financial Highlights

In the second quarter, Waystar reported a total revenue of $319.7 million, an 18% increase compared to the previous year. The company's net income reached $40.9 million, with a net income margin of 13%. Further emphasizing their strong financial standing, Waystar's non-GAAP net income was reported at $83.3 million, translating to a diluted earnings per share of $0.43.

Additional significant metrics include an adjusted EBITDA of $136.7 million, which yields an impressive margin of 43% as well as strong operational cash flows of $59.4 million. The company has also increased its guidance for the remainder of 2026, further reflecting confidence in its future performance.

Insights from Leadership

Matt Hawkins, CEO of Waystar, emphasized the company's strategic position that interlinks healthcare providers, payers, and patients. He noted that the growing adoption of their innovative platform significantly contributes to improved healthcare performance. Hawkins stated, "Waystar delivered another solid quarter, driven by healthy demand, disciplined execution, and growing provider adoption. Our unique position connecting providers, payers, and patients — combined with the breadth of our platform, the scale of our data, and the impact of our AltitudeAI capabilities — positions us strongly for continued growth."

Detailed Financial Analysis

• - Client Growth: During this quarter, Waystar saw 1,453 clients contributing over $100,000 in LTM revenue, which is an increase of 15% year-over-year.
• - Revenue Breakdown:

- Subscription revenue accounted for $176.3 million, reflecting a 34% year-over-year growth.
- Volume-based revenue reported was $142.1 million, marking a 3% increase.
- Provider revenue rose to $231.8 million, showing a 23% year-over-year increase, while patient revenue increased to $87.9 million, a 7% rise.

Financial Outlook

For the total fiscal year of 2026, Waystar anticipates total revenues to fall within the range of $1.276 billion to $1.294 billion, with an adjusted EBITDA projected between $535 million and $545 million. Their non-GAAP net income is expected between $322 million and $340 million, and diluted non-GAAP net income per share is anticipated to be between $1.61 and $1.70.

Upcoming Events and Webcasts

Waystar has scheduled a conference call today at 4:30 p.m. Eastern Time to discuss these financial results in further detail. Interested investors can access the live audio conference on Waystar's investor relations website and will also find an archived version available for those unable to attend live.

Conclusion

Waystar's second quarter results for 2026 showcase the company’s resilience and growth in a competitive market. With a continued focus on enhancing their services and expanding their client base, Waystar is set to remain a significant player in the healthcare payment software industry. As they enhance their offerings and invest in technology, stakeholders and investors can look forward to even stronger results in the future.